NDPP – Potential game-changing programme to delay or stop onset of Type 2 diabetes

Guest Blog by Louise Ansari, Director of Prevention, Diabetes UK

Louise AnsariMost readers of 2020Health will be concerned about the rising tide of diabetes – some may even have heard that there is a new push on prevention. As Diabetes Week 2015 begins, here’s some more detail on the heralded National Diabetes Prevention Programme (NDPP), jointly being developed by NHS England, Public Health England and Diabetes UK

A few facts and figures first. It’s announced this week that 3.3 million people in the UK now have diagnosed diabetes – and another 590,000 people have undiagnosed Type 2 diabetes. It’s a staggering and shameful fact that someone is diagnosed every three minutes, especially when evidence exists that up to 80 per cent of cases of Type 2 diabetes are preventable, or at least onset can be delayed by up to five years.

More than 20,000 people with diabetes die before their time every year. The condition is a leading cause of preventable sight loss in people of working age and is a major contributor to kidney failure, heart attack, and stroke. As well as the human cost, diabetes accounts for around 10 per cent of the annual NHS budget – £10 billion a year.

Many whole-society measures are necessary, including reformulation of food and drink products to reduce sugar and fat, and a reduction in portion size. Whole population health could improve if such measures were taken systematically. But we know as well from five international randomised control trials that high risk people who go through a programme focussing on improving diet and exercise will significantly reduce their risk of getting Type 2 diabetes.

That’s where NDPP comes in. We will deliver at scale, an evidence based lifestyle change programme focused on lowering weight, increasing physical activity and improving the diet of those individuals identified as being at high risk of developing Type 2 diabetes.

The singular aim of the programme is to reduce people’s risk of developing Type 2 diabetes across England. This will improve the health of the nation whilst at the same time relieve the system of a major financial burden, both in reducing costs of day to day diabetes management, but also potentially reducing the much higher costs of managing complications such as limb amputation.

The NHS Health Check programme will provide a key referral route into the programme – many GPs already say they wished they had a programme to refer people onto once the Health Check shows them to be at high risk. There will also be other referral routes into the programme – all based around a NICE validated risk score, and pharmacists, GPs and community groups will all play a key role here. Often GPs will already have identified individuals at high risk and will have information on their systems enabling them to refer into the NDPP.

The NDPP is undertaking a review of existing diabetes prevention programmes to establish an evidence base of effective interventions, and this will be published later in the summer. We are currently working with seven local ‘demonstrator sites’ (Birmingham South and Central CCG, Bradford City CCG, Durham County Council, Herefordshire CCG/LA, Medway CCG/LA, Salford CCG/LA and Southwark Council and CCG) to learn practical lessons from delivery, testing and evaluation approaches.   The demonstrator sites will pilot new approaches and help co-design the service. We’re also setting up reference groups of experts to inform clinical design, and patients to inform the design from a user experience perspective. During 2015/16 we are hoping to target up to 10,000 people to participate in an intervention. Procurement planning is also underway for future national roll-out, as is planning for evaluation of the scheme, to provide the robust evidence of efficacy here that was shown in international trial

The NDPP has the potential to be a truly game-changing programme, reducing pressure on the system, helping people regain better health, and delay or stop a diagnosis of Type 2 diabetes, a progressive and ultimately severe condition

Diabetes UK home page

If you want to receive regular information on the NDPP please email diabetesprevention@phe.gov

 

Advertisements

About Julia Manning

Julia Manning is a social entrepreneur, writer, campaigner and commentator. She is based in London and is the founder and Chief Executive of 2020health, an independent, social enterprise Think Tank whose aim is to Make Health Personal. Through networking, technology, research, relationships and campaigning 2020health has influenced opinion and action in fields as diverse as bioethics, alcohol, emerging technologies, fraud, education, consumer technology and vaccination. Julia studied visual science at City University and became a member of the College of Optometrists in 1991. Her career has included being a visiting lecturer at City University, a visiting clinician at the Royal Free Hospital, working with south London Primary Care Trusts and as a Director of the UK Institute of Optometry. She specialised in diabetes (University of Warwick Certificate in Diabetic Care) and founded Julia Manning Eyecare in 2004, a home and prison visiting practice for people with mental and physical disabilities using the latest digital technology, which she sold to Healthcall (now part of Specsavers) in 2009. Experiences of working in the NHS, contributing to policy development, raising two children in the inner-city and standing in the General Election in Bristol in 2005 led to Julia forming 2020health at the end of 2006. Julia is a regular guest on TV and radio shows such as BBC News, ITV’s Daybreak/ GMB, Channel 5 News, BBC 1′s The Big Questions, BBC Radio, LBC and has taken part in debates and contributed to BBC’s Newsnight, Panorama, You and Yours and ITV’s The Week. She is mum to a rugby-mad son, a daughter passionate about Shakespeare, and wife of a comprehensive school assistant head-teacher. She loves gardening, ballet, Zimbabwe, her Westies Skye and Angus, is an honorary research associate at UCL and a Fellow of the RSA.
This entry was posted in Diabetes, NHS, NHS England, Public Health and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s